Medical Propellants Market Research Report
商品番号 : SMB-69930
| 出版社 | Market Research Future |
| 出版年月 | 2024年11月 |
| ページ数 | 116 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Market Overview
In 2023, the Medical Propellants Market was valued at USD 0.27 billion. The sector is expected to increase from USD 0.30 billion in 2024 to USD 0.72 billion by 2032, with a compound yearly growth rate (CAGR) of 10.16% for the forecast period (2024-2032). The increased prevalence of respiratory disorders such as asthma and chronic obstructive pulmonary disease, together with technological improvements in inhalation devices, are driving the global metered-dose inhaler market.
2023 年の医療用推進剤市場は 2 億 7,000 万米ドルと評価されました。このセクターは、2024年の3億米ドルから2032年までに7億2,000万米ドルに増加すると予想されており、予測期間(2024年から2032年)の年間複合成長率(CAGR)は10.16%となる。
The rising frequency of respiratory illnesses, such as asthma and chronic obstructive pulmonary disease (COPD), is predicted to have a significant impact on the medical propellants industry. This effect is mostly caused by an increase in demand for inhalation-based therapies and devices that require propellants. As respiratory ailments become more widespread, so does the demand for inhalers, which are critical equipment for administering medication to the lungs. These inhalers use propellants to appropriately administer medication.
Market Segment insights
The Medical Propellants Market is divided into three types: HFA-134A, HFA-227EA, and HFA-152A.
The Market is divided into two segments based on application: manual metered dosage inhalers and breath metered dose inhalers.
The market has been divided into three segments based on end users: medical device businesses, contract manufacturing organizations (CMOs), and research laboratories.
Regional insights
North America held the biggest market share in 2023. However, Europe is expected to develop at the greatest CAGR throughout the forecast period, 2024-2032.
The Medical Propellants market in North America is expanding rapidly, owing to technical developments, a favorable regulatory environment, and rising healthcare demands. Furthermore, the market is driven by sophisticated healthcare infrastructure and significant investment in R&D, which allows for the development of cutting-edge Medical Propellants.
The Americas region is followed by Europe, which is further divided into Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe. The Medical Propellants market in Europe is characterized by ongoing innovation in propellant formulation. A mature pharmaceutical business in Europe ensures robust distribution channels and cooperation, as well as compliance with tough European laws that assure high safety and efficacy standards, building customer confidence. The rising prevalence of respiratory disorders, fueled by an aging population, heightens the demand for advanced, high-quality inhalers.
Asia-Pacific is likely to grow significantly, becoming the fastest growing region throughout the forecast period, with substantial growth driven by a number of major factors. Rapidly expanding healthcare infrastructure and increased investment in healthcare infrastructure in countries such as China, India, and Japan are driving demand for sophisticated inhalers that use medicinal propellants.
Major Players
Koura (US), SRF (India), DAIKIN (Japan), Linde PLC (UK), Xiamen Juda Chemical & Equipment Co., Ltd. (China), Jiangsu July Chemical Co., Ltd. (China), Beijing Yuji Technology Development Co., Ltd. (China), Zhejiang Jushen New Material Technology Co., Ltd. (China), Zhejiang fotech international co., ltd. (China), and Changshu 3F Fluorochemical Industry Co., Ltd.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
A propellant is a substance used to propel a medication from an aerosol canister or inhaler. These propellants are typically gases that help deliver medication in a fine mist or spray to ensure it can be effectively inhaled or applied.
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA FLOW
3.2.1 Data Mining Process
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
3.4.1 Secondary Research data flow:
3.5 PRIMARY RESEARCH:
3.5.1 Primary Research DATA FLOW:
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
3.6.1 Revenue Analysis Approach
3.7 DATA FORECASTING
3.7.1 Data forecasting Type
3.8 DATA MODELING
3.8.1 microeconomic factor analysis:
3.8.2 Data modeling:
3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 Rising incidence of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD)
4.2.2 Technological Advancements in Inhalation Devices
4.2.3 Increased awareness about preventive healthcare
4.3 RESTRAINTS
4.3.1 High costs of advanced propellants
4.4 OPPORTUNITY
4.4.1 Emerging markets offer significant growth opportunities
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL
5.1.1 Threat of New Entrants
5.1.2 BARGAINING POWER OF SUPPLIERS
5.1.3 Threat of Substitutes
5.1.4 Bargaining Power of Buyers
5.1.5 Intensity of Rivalry
5.2 IMPACT OF COVID-19 ON THE GLOBAL MEDICAL PROPELLANTS MARKET
6 GLOBAL MEDICAL PROPELLANTS MARKET, BY TYPE
6.1 OVERVIEW
6.2 HFA 134A
6.3 HFA 227EA
6.4 HFA-152A
7 GLOBAL MEDICAL PROPELLANTS MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 PRESS METERED DOSE INHALERS
7.3 BREATH ACTUATED METERED DOSE INHALERS
8 GLOBAL MEDICAL PROPELLANTS MARKET, BY END USER
8.1 OVERVIEW
8.2 MEDICAL DEVICE COMPANIES
8.3 CONTRACT MANUFACTURING ORGANIZATION (CMO)
8.4 RESEARCH LABORATORIES
9 GLOBAL MEDICAL PROPELLANTS MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 us
9.2.2 canada
9.3 EUROPE
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 ASIA-PACIFIC
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 REST OF THE WORLD
9.5.1 middle east & africa
9.5.2 south america
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 MARKET SHARE ANALYSIS, 2023
10.3 COMPETITOR DASHBOARD
10.4 PUBLIC PLAYERS STOCK SUMMARY
10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.6.1 Facility expansion
11 COMPANY PROFILES
11.1 KOURA
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 products OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 SRF
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 Product OFFERed
11.2.4 KEY DEVELOPMENTS
11.2.5 KEY STRATEGIES
11.3 DAIKIN CHEMICAL EUROPE GMBH
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 productS OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 KEY STRATEGIES
11.4 LINDE PLC
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 productS OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.4.6 KEY STRATEGIES
11.5 XIAMEN JUDA CHEMICAL & EQUIPMENT CO., LTD
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 SWOT ANALYSIS
11.5.6 KEY STRATEGIES
11.6 JIANGSU JULY CHEMICAL CO., LTD.
11.6.1 COMPANY OVERVIEw
11.6.2 FINANCIAL OVERVIEW
11.6.3 Product OFFERed
11.6.4 KEY DEVELOPMENTS
11.6.5 KEY STRATEGIES
11.7 BEIJING YUJI TECHNOLOGY DEVELOPMENT CO., LTD.
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 SWOT ANALYSIS
11.7.6 KEY STRATEGIES
11.8 ZHEJIANG JUSHEN NEW MATERIAL TECHNOLOGY CO., LTD.
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 Product OFFERed
11.8.4 KEY DEVELOPMENTS
11.8.5 KEY STRATEGIES
11.9 ZHEJIANG FOTECH INTERNATIONAL CO., LTD
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 Product OFFERed
11.9.4 KEY DEVELOPMENTS
11.9.5 SWOT ANALYSIS
11.9.6 KEY STRATEGIES
11.10 CHANGSHU 3F FLUOROCHEMICAL INDUSTRY CO., LTD.
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 Product OFFERed
11.10.4 KEY DEVELOPMENTS
11.10.5 KEY STRATEGIES
12 DATA CITATIONS
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 3 GLOBAL MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 4 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA 134A, BY REGION, 2019–2032 (USD MILLION)
TABLE 5 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA 134A, BY REGION, 2019–2032 (METRIC TON)
TABLE 6 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA 227EA, BY REGION, 2019–2032 (USD MILLION)
TABLE 7 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA 227EA, BY REGION, 2019–2032 (METRIC TON)
TABLE 8 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA-152A, BY REGION, 2019–2032 (USD MILLION)
TABLE 9 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA-152A, BY REGION, 2019–2032 (METRIC TON)
TABLE 10 GLOBAL MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 11 GLOBAL MEDICAL PROPELLANTS MARKET, FOR PRESS METERED DOSE INHALERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 12 GLOBAL MEDICAL PROPELLANTS MARKET, FOR BREATH ACTUATED METERED DOSE INHALERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 13 GLOBAL MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 14 GLOBAL MEDICAL PROPELLANTS MARKET, FOR MEDICAL DEVICE COMPANIES, BY REGION, 2019–2032 (USD MILLION)
TABLE 15 GLOBAL MEDICAL PROPELLANTS MARKET, FOR CONTRACT MANUFACTURING ORGANIZATION (CMO), BY REGION, 2019–2032 (USD MILLION)
TABLE 16 GLOBAL MEDICAL PROPELLANTS MARKET, FOR RESEARCH LABORATORIES, BY REGION, 2019–2032 (USD MILLION)
TABLE 17 GLOBAL MEDICAL PROPELLANTS MARKET, BY REGION, 2019–2032 (USD MILLION)
TABLE 18 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 19 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 20 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 21 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 22 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 23 US: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 24 US: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 25 US: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 26 US: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 27 CANADA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 28 CANADA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 29 CANADA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 30 CANADA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 31 EUROPE: MEDICAL PROPELLANTS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 32 EUROPE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 33 EUROPE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 34 EUROPE: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 35 EUROPE: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 36 GERMANY: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 37 GERMANY: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 38 GERMANY: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 39 GERMANY: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 40 FRANCE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 41 FRANCE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 42 FRANCE: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 43 FRANCE: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 44 UK: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 45 UK: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 46 UK: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 47 UK: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 48 ITALY MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 49 ITALY MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 50 ITALY MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 51 ITALY: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 52 SPAIN: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 53 SPAIN: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 54 SPAIN: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 55 SPAIN: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 56 REST OF EUROPE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 57 REST OF EUROPE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 58 REST OF EUROPE: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 59 REST OF EUROPE: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 60 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 61 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 62 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 63 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 64 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 65 CHINA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 66 CHINA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 67 CHINA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 68 CHINA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 69 INDIA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 70 INDIA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 71 INDIA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 72 INDIA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 73 JAPAN: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 74 JAPAN: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 75 JAPAN: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 76 JAPAN: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 77 AUSTRALIA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 78 AUSTRALIA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 79 AUSTRALIA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 80 AUSTRALIA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 81 SOUTH KOREA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 82 SOUTH KOREA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 83 SOUTH KOREA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 84 SOUTH KOREA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 85 REST OF ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 86 REST OF ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 87 REST OF ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 88 REST OF ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 89 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 90 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 91 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 92 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 93 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 94 MIDDLE EAST & AFRICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 95 MIDDLE EAST & AFRICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 96 MIDDLE EAST & AFRICA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 97 MIDDLE EAST & AFRICA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 98 SOUTH AMERICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 99 SOUTH AMERICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019–2032 (METRIC TON)
TABLE 100 SOUTH AMERICA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 101 SOUTH AMERICA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 102 FACILITY EXPANSION
TABLE 103 KOURA: PRODUCT OFFERED
TABLE 104 KOURA: KEY DEVELOPMENT
TABLE 105 SRF: PRODUCTS OFFERED
TABLE 106 DAIKIN CHEMICAL EUROPE GMBH: PRODUCT OFFERED
TABLE 107 LINDE PLC: PRODUCT OFFERED
TABLE 108 XIAMEN JUDA CHEMICAL & EQUIPMENT CO., LTD: PRODUCTS OFFERED
TABLE 109 JIANGSU JULY CHEMICAL CO., LTD.: PRODUCTS OFFERED
TABLE 110 BEIJING YUJI TECHNOLOGY DEVELOPMENT CO., LTD.: PRODUCTS OFFERED
TABLE 111 ZHEJIANG JUSHEN NEW MATERIAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
TABLE 112 ZHEJIANG FOTECH INTERNATIONAL CO., LTD.: PRODUCTS OFFERED
TABLE 113 CHANGSHU 3F FLUOROCHEMICAL INDUSTRY CO., LTD.: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL MEDICAL PROPELLANTS MARKET: STRUCTURE
FIGURE 2 GLOBAL MEDICAL PROPELLANTS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL MEDICAL PROPELLANTS MARKET
FIGURE 6 GLOBAL MEDICAL PROPELLANTS MARKET, TYPE, 2023 & 2032 (USD MILLION)
FIGURE 7 GLOBAL MEDICAL PROPELLANTS MARKET, BY TYPE, 2023 & 2032 (USD MILLION)
FIGURE 8 GLOBAL MEDICAL PROPELLANTS MARKET SHARE (%), BY TYPE, 2023
FIGURE 9 GLOBAL MEDICAL PROPELLANTS MARKET, APPLICATION, 2023 & 2032 (USD MILLION)
FIGURE 10 GLOBAL MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)
FIGURE 11 GLOBAL MEDICAL PROPELLANTS MARKET SHARE (%), BY APPLICATION, 2023
FIGURE 12 GLOBAL MEDICAL PROPELLANTS MARKET, END USER, 2023 & 2032 (USD MILLION)
FIGURE 13 GLOBAL MEDICAL PROPELLANTS MARKET, BY END USER, 2023 & 2032 (USD MILLION)
FIGURE 14 GLOBAL MEDICAL PROPELLANTS MARKET SHARE (%), BY END USER, 2023
FIGURE 15 GLOBAL MEDICAL PROPELLANTS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
FIGURE 16 GLOBAL MEDICAL PROPELLANTS MARKET SHARE, BY REGION, 2023 (% SHARE)
FIGURE 17 NORTH AMERICA MARKET ANALYSIS: MEDICAL PROPELLANTS MARKET, 2019-2032 (USD MILLION)
FIGURE 18 NORTH AMERICA MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 19 NORTH AMERICA MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 20 EUROPE MARKET ANALYSIS: MEDICAL PROPELLANTS MARKET, 2019-2032 (USD MILLION)
FIGURE 21 EUROPE MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 22 EUROPE MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 23 ASIA-PACIFIC MARKET ANALYSIS: MEDICAL PROPELLANTS MARKET, 2019-2032 (USD MILLION)
FIGURE 24 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 25 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 26 REST OF THE WORLD: MARKET ANALYSIS: MEDICAL PROPELLANTS MARKET, 2019-2032 (USD MILLION)
FIGURE 27 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 28 REST OF THE WORLD MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 (%)
FIGURE 29 GLOBAL MEDICAL PROPELLANTS MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023
FIGURE 30 COMPETITOR DASHBOARD: GLOBAL MEDICAL PROPELLANTS MARKET
FIGURE 31 KOURA: SWOT ANALYSIS
FIGURE 32 SRF: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 LINDE PLC SWOT ANALYSIS
FIGURE 34 XIAMEN JUDA CHEMICAL & EQUIPMENT CO., LTD: SWOT ANALYSIS
FIGURE 35 BEIJING YUJI TECHNOLOGY DEVELOPMENT CO., LTD.: SWOT ANALYSIS
FIGURE 36 ZHEJIANG FOTECH INTERNATIONAL CO., LTD.: SWOT ANALYSIS
Market Research Future(マーケットリサーチフューチャー)はインドに主拠点を置き、技術的および経済的進歩に関して貴重な分析とデータを提供しています。調査結果にはMarket Research Futureのアナリストが直接著名な市場プレーヤーから入手した関連情報も含まれています。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
パターン1
| シングルユーザ | マルチユーザ | エンタープライズサイト |
| USD4,950 | USD5,950 | USD7,250 |
パターン2
| シングルユーザ | マルチユーザ | エンタープライズサイト |
| USD2,950 | USD3,950 | USD 5,250 |
ご購入に関するご案内
- 価格
- ウェブサイトに記載の外貨(定価)を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。
- 手数料はいただいておりません。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルの閲覧・レポート内容の利用が可能です。
- マルチユーザライセンス
- 同一企業内(関連企業除く)10名までレポートファイルのご共有可能です。
- エンタープライズワイドライセンス
- 同一企業であれば、人数無制限でレポートファイルの閲覧・レポート内容の利用が可能です。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- ご注文後2営業日以内
- その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
レポートの詳細、価格、購入等に関するご質問はいつでもお気軽にお問合せください。
最新調査レポート